Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

OrganiGram (OGI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.02 per share a year ago. These figures are ...

Reports Q3 adjusted EBITDA $5.694M vs. $3.465M. “In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of ...